We compared our bipolar disorder cases against our set of schizophrenia cases from the same population who had been examined by the same methods (n=440).
14 The copy number variants (CNVs) were classified into size categories as in our previous report. eTable 1 shows the results. Compared with bipolar disorder, in the schizophrenia sample we observed a significant excess of large deletions (PϽ.001) and total large CNVs (PϽ.001) and a trend for excess large duplications (P = .053).
DIFFERENCES BETWEEN SAMPLES USED IN SCHIZOPHRENIA ANALYSIS REPORTED PREVIOUSLY AND SCHIZOPHRENIA-CONTROL COMPARISONS IN THIS ANALYSIS
There are small differences with respect to the analyzed individuals reported herein and the ones described in our schizophrenia article. 14 In cases, this is caused by the exclusion of schizoaffective cases in the current analysis. The differences with regard to controls are caused by reanalysis of a small subset of them. Some of the control data were processed with the use of different reference batches, which enabled us to include more controls in the current analysis.
CNVs THAT OCCURRED MORE OFTEN IN BIPOLAR DISORDER CASES THAN CONTROLS
Although we did not observe an overall increase of CNV burden in bipolar cases compared with controls, some individual CNVs were more common in cases than controls. None was significantly associated after correction for multiple testing. Those CNVs for which there was an uncorrected nominal significance level of ␣Յ.05 are presented in eTable 2.
ANALYSIS OF CNVs IN REGIONS PREVIOUSLY REPORTED TO SHOW ASSOCIATIONS IN BIPOLAR DISORDER SAMPLES
We investigated whether CNV regions previously hypothesized to be involved in susceptibility to bipolar disorder were affected by CNVs in our data. The CNVs on chromosomes 1p34. 3, 14q23.3, and 22q12.3, affecting GLUR7 (official symbol, GRIK3) , AKAP5, and CACNG2, respec- tively, were studied. 21 No deletions or duplications were found. The other studied locus was 3q13.3, reported to harbor duplication in the GSK3B gene. 22 This gene codes for glycogen synthase kinase, a key player in the Wnt signaling pathway and a target of lithium.
22 No CNVs were detected at this locus in bipolar cases.
SINGLETON EVENTS: COMPARISON OF OUR DATA WITH PREVIOUS STUDIES
With the use of PLINK, 24 deletions-only and duplicationsonly data sets were generated. In these data sets, a deletion was still defined as a single-occurrence event even if there was duplication at the same region. The same rule was applied to duplications. Therefore, the number of single-occurrence deletions and single-occurrence duplications does not sum to the total number of singleoccurrence events.
The power in our sample at ␣ = .05 to detect a significant difference with the effect size observed by Zhang et al 20 (␦=0.11) was 95%. For comparison, the power to detect a significant difference (␦= 0.11) with their sample size was 71% (␣ = .05). As mentioned in the "Comment" section, the Zhang et al study 20 used a higher-resolution array (Affymetrix 6.0) and had a smaller sample size. Both of these factors can lead to the observation of a higher number of singleton CNVs in their study and could explain the differences from our study (eTable 3).
ANALYSIS OF GENES WITHIN CNVs FOUND ONLY IN CASES
We provide a list of genes within all CNVs that were present in cases but not in controls (eTable 4). The list includes not only singleton CNVs (those found once in the data set) but also CNVs found in more than 1 case, but not in any control. Where several CNVs mapped to the same region, they did not always fully overlap. The start and end points in the table refer to the total region covered by such a cluster of CNVs. The list contains several intriguing candidate genes (eg, neuroligin 1, neuregulin 3, and the ␣-2 catenin), although we have no specific evidence that any contribute to susceptibility to bipolar disorder.
ANALYSIS OF CNVs THAT DISRUPT GENES
The global burden of CNVs in cases and controls with respect to genes that are deleted, duplicated, or disrupted by CNVs was estimated by using PLINK 24 1.05. Only CNVs that overlapped with at least 1 gene, on the basis of hg18 genomic coordinates, were taken into account. This analysis was performed for all CNVs and then for the CNVs that occurred only once in the data. Table 4 in the main article shows the main chromosomal regions with CNVs associated with schizophrenia and the number of the corresponding CNVs in the bipolar disorder cases and controls. Herein we provide more information on these CNVs. A deletion at 15q13.3 loci has been found to be associated with schizophrenia in 2 large studies of schizophrenia.
CNVs PREVIOUSLY ASSOCIATED WITH SCHIZOPHRENIA
12,13 Deletion in the same region was reported to be associated with mental retardation and seizures. 16 No deletions were observed in bipolar disorder, but 2 cases and no controls were found to harbor duplications in this region (Fisher exact test, P=.14). The significance (or otherwise) of duplications in this region is not yet known from other studies. ANXA8L2, LOC728449, FAM21B, ASAH2C, LOC727950, LOC100132209, CTGLF6, LOC100133093, ANXA8, LOC653110, ZNF488, RBP3, GDF2, GDF10, PTPN20B, FRMPD2L1, LOC644021, LOC644054, LOC100133265, FRMPD2, MAPK8, ARHGAP22, C10orf64, LOC642343, WDFY4, LRRC18, C10orf72, C10orf73, LOC728883, C10orf128, LOC100132730, C10orf71, LOC100130757, DRGX, LOC100128032, ERCC6, PGBD3, CHAT, SLC18A3, C10orf53, OGDHL, LOC727726, FAM21D, LOC728955, CTGLF5, TIMM23B, LOC100133089, CTGLF4 1  14  21 604 337  21 840 943  3  TRA@, TRAV22, TRAV23DV6, TRDV1, TRAV24, TRAV25, TRAV26-1,  TRAV8-7, TRAV27, TRAV29DV5, TRAV30, TRAV26-2, TRAV34,  TRAV35, TRAV36DV7, TRAV38 A region on 16p11.2 has been implicated in schizophrenia 11 and autism. 10 In our sample, duplications at 16p11.2 were found in 3 cases and 1 control, a 5-fold increase in frequency (0.2% vs 0.04%; Fisher exact test, P=.15). The deletion associated with this region was found in none of the cases and in 3 controls. It should be noted that the 16p11.2 locus is covered by 7 markers on the NspI array. Therefore, it would have been filtered out by the quality control criterion of 10 or more consecutive markers on each array. To target this region, data for every individual who showed a CNV in this region, detected by the single-nucleotide polymorphisms (SNPs) on the StyI array, were individually inspected with the Affymetrix Genotyping console v2.1 software. This CNV was accepted if, in addition to the SNPs on the StyI array, all markers on the NspI array within this region also showed a deviation in the log 2 ratios in the same direction.
A deletion on the short arm of chromosome 17 (17p12) has been found to be associated with schizophrenia (PϽ.001).
14 PMP22, one of the affected genes in this region, is the causal gene for hereditary neuropathy with liability to pressure palsies when deleted 25 and CharcotMarie-Tooth disease type 1A when duplicated. 26 In our sample, 1 bipolar case had the duplication in this approximately 1.5-Mb region. No duplications or deletions were observed in the controls.
Although deletions in the velocardiofacial syndrome region have been implicated in bipolar disorder, 27 we did not observe any deletions in the bipolar data set. We found 8 people from the control data set harboring a reciprocal duplication in this region (6 of them spanning the full region). All were part of the UK Blood Service sample set. It has been suggested that the microduplication of 22q11.2 shares some characteristics with velocardiofacial syndrome. [28] [29] [30] Our data add strong evidence against the hypothesis that the duplication of 22q11.2 predisposes to bipolar disorder or schizophrenia.
ANALYSIS OF AFFECTED FAMILY MEMBERS
In 2 of the individuals with CNVs included in Table 4 in the main article, we had DNA from both parents, and the father was also affected by bipolar disorder in both cases. The probands and the parents were genotyped with an independent platform both to validate the CNVs and to examine the transmission in the family. We used quad arrays Illumina Inc, San Diego, California) following the manufacturer's protocols (http://www .Illumina.com). The 1q21.1 duplication was confirmed in the proband. DNA was available from both parents. The CNV was also found in the father, who also had bipolar I disorder.
One of the probands with the 16p11.2 duplication also had both parents providing DNA. The duplication was confirmed in the proband but was not found in either parent (paternity was confirmed from the SNP data on the array). The father of the proband also had bipolar I disorder, and both he and his daughter had a similar presentation of illness, with severe manic and depressive episodes but no psychotic features.
The findings from the quad arrays on the 2 families are shown in eFigures 1, 2, 3, 4, 5, and 6. eFigure 6. Healthy mother of proband with 16p11.2 duplication. Neither parent had the duplication. Single-nucleotide polymorphism analysis showed that the duplication arose from the maternal chromosomes.
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